Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brain Mechanisms and Targeting Insomnia in Major Depression
NCT00628914Phase 4Unknown
- Sponsor
- University of California, Los Angeles
- Start
- May 2008
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of eszopiclone in major depressive disorder (MDD), Insomnia, sponsored by University of California, Los Angeles. Status: unknown.
02
Drugs
eszopiclone
03
Conditions
major depressive disorder (MDD)Insomnia
Beyond the preview
Go deeper on NCT00628914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00628914.